- Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage CNBC
- Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update CNN
- FDA approves Novo Nordisk’s Wegovy for use in reducing heart attack risks Yahoo Finance
You can read the full story here: “FDA Approves Novo Nordisk’s Wegovy for Reducing Cardiovascular Complications in Adults with Obesity and Heart Disease” .